Earnings Feed
Start Free
|4Jan 26, 4:43 PM ET

Dayno Jeffrey M. 4

Research Summary

AI-generated summary

Updated

Harmony Biosciences (HRMY) CEO Jeffrey Dayno Receives RSUs, Exercises Options

What Happened
Jeffrey M. Dayno, President, CEO and a director of Harmony Biosciences (HRMY), received derivative awards (restricted stock units / option-related awards) totaling 237,500 units on Jan 22, 2026 (184,600 + 52,900). He also exercised/converted a total of 23,500 option shares on Jan 24–25, 2026 (10,500 and 13,000). To satisfy required tax withholdings, the issuer withheld 4,785 shares (Jan 24) and 5,654 shares (Jan 25) at $36.82 per share, generating cash withholding amounts of $176,184 and $208,180 (combined $384,364). The grants are derivative awards (RSUs/options) with vesting schedules noted in the filing.

Key Details

  • Transaction dates/prices:
    • Jan 22, 2026: Grant/award of 184,600 and 52,900 derivative units (reported as acquired at $0.00; RSU/derivative).
    • Jan 24, 2026: Exercise/conversion of 10,500 shares (acquired), and 4,785 shares withheld for tax at $36.82 ($176,184).
    • Jan 25, 2026: Exercise/conversion of 13,000 shares (acquired), and 5,654 shares withheld for tax at $36.82 ($208,180).
  • Shares withheld for taxes: 10,439 total shares; withholding cash value $384,364.
  • Shares owned after the transactions: not specified in the provided Form 4 summary.
  • Footnotes of note:
    • F1: Shares were withheld by the issuer to satisfy income tax withholding on RSU vesting.
    • F2–F5: Awards/options are subject to multi-year vesting schedules (vesting begins on various dates in 2025–2027 and may vest quarterly or annually as specified).
  • Filing timeliness: no late filing flag is indicated in the information provided.

Context and plain-language takeaways:

  • These filings show a mix of awards (acquisitions of RSU/derivative interests) and option exercises. The large entry on Jan 22 is an award/grant (acquisition) but the awards vest over future dates—so they are not immediately liquid shares.
  • The exercised option shares had portions withheld to cover tax obligations (a common, non-market sale administrative action), not open-market stock sales. That withholding is recorded as a disposal (F) for tax purposes.
  • For retail investors: awards/RSUs indicate compensation and potential future share issuance subject to vesting; the withheld shares for taxes are routine and do not necessarily indicate a decision to sell stock for investment reasons.